308 related articles for article (PubMed ID: 27235684)
21. Molecular Imaging for Cancer Immunotherapy: Seeing Is Believing.
Saeed M; Xu Z; De Geest BG; Xu H; Yu H
Bioconjug Chem; 2020 Feb; 31(2):404-415. PubMed ID: 31951380
[TBL] [Abstract][Full Text] [Related]
22. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
Ikeda H
Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
[TBL] [Abstract][Full Text] [Related]
23. Tumor reactive T cells get a boost.
Pardoll DM
Nat Biotechnol; 2002 Dec; 20(12):1207-8. PubMed ID: 12454671
[No Abstract] [Full Text] [Related]
24. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene.
Doubrovin MM; Doubrovina ES; Zanzonico P; Sadelain M; Larson SM; O'Reilly RJ
Cancer Res; 2007 Dec; 67(24):11959-69. PubMed ID: 18089827
[TBL] [Abstract][Full Text] [Related]
25. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue.
Griessinger CM; Kehlbach R; Bukala D; Wiehr S; Bantleon R; Cay F; Schmid A; Braumüller H; Fehrenbacher B; Schaller M; Eichner M; Sutcliffe JL; Ehrlichmann W; Eibl O; Reischl G; Cherry SR; Röcken M; Pichler BJ; Kneilling M
J Nucl Med; 2014 Feb; 55(2):301-7. PubMed ID: 24434289
[TBL] [Abstract][Full Text] [Related]
26. Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.
Peinert S; Kershaw MH; Prince HM
Immunotherapy; 2009 Nov; 1(6):905-12. PubMed ID: 20635906
[No Abstract] [Full Text] [Related]
27. Dual-specific T cells combine proliferation and antitumor activity.
Kershaw MH; Westwood JA; Hwu P
Nat Biotechnol; 2002 Dec; 20(12):1221-7. PubMed ID: 12415288
[TBL] [Abstract][Full Text] [Related]
28. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.
Ohno K; Yoshizawa H; Tsukada H; Takeda T; Yamaguchi Y; Ichikawa K; Maruyama Y; Suzuki Y; Suzuki E; Arakawa M
J Immunol; 1996 May; 156(10):3875-81. PubMed ID: 8621926
[TBL] [Abstract][Full Text] [Related]
29. γδ T cells in cancer immunotherapy.
Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
[TBL] [Abstract][Full Text] [Related]
30. Cellular immunotherapy of cancer: an overview and future directions.
Tao Z; Li S; Ichim TE; Yang J; Riordan N; Yenugonda V; Babic I; Kesari S
Immunotherapy; 2017 Jun; 9(7):589-606. PubMed ID: 28595516
[TBL] [Abstract][Full Text] [Related]
31. Immuno-PET Imaging of Engineered Human T Cells in Tumors.
Mall S; Yusufi N; Wagner R; Klar R; Bianchi H; Steiger K; Straub M; Audehm S; Laitinen I; Aichler M; Peschel C; Ziegler S; Mustafa M; Schwaiger M; D'Alessandria C; Krackhardt AM
Cancer Res; 2016 Jul; 76(14):4113-23. PubMed ID: 27354381
[TBL] [Abstract][Full Text] [Related]
32. Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.
Chicaybam L; Bonamino MH
Int Rev Immunol; 2014 Oct; 33(5):402-16. PubMed ID: 24911925
[TBL] [Abstract][Full Text] [Related]
33. Adoptively transferred anti-CD3-activated T cells for human tumor immunotherapy.
Gold JE
J Clin Oncol; 1993 Sep; 11(9):1836-7. PubMed ID: 8355052
[No Abstract] [Full Text] [Related]
34. Adoptive T-cell therapy for cancer: The era of engineered T cells.
Bonini C; Mondino A
Eur J Immunol; 2015 Sep; 45(9):2457-69. PubMed ID: 26202766
[TBL] [Abstract][Full Text] [Related]
35. Quantitative imaging of the T cell antitumor response by positron-emission tomography.
Dubey P; Su H; Adonai N; Du S; Rosato A; Braun J; Gambhir SS; Witte ON
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1232-7. PubMed ID: 12547911
[TBL] [Abstract][Full Text] [Related]
36. Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells.
Li J; Theofanous L; Stickel S; Bouton-Verville H; Burgin KE; Jakubchak S; Wagner TE; Wei Y
Int J Oncol; 2007 Jul; 31(1):193-7. PubMed ID: 17549421
[TBL] [Abstract][Full Text] [Related]
37. PET imaging of the immune system: immune monitoring at the whole body level.
Singh AS; Radu CG; Ribas A
Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):281-90. PubMed ID: 20639814
[TBL] [Abstract][Full Text] [Related]
38. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
Cohen PA; Peng L; Kjaergaard J; Plautz GE; Finke JH; Koski GK; Czerniecki BJ; Shu S
Crit Rev Immunol; 2001; 21(1-3):215-48. PubMed ID: 11642606
[TBL] [Abstract][Full Text] [Related]
39. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
40. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]